Xi'an Century Shengkang Pharmaceutical

Xi'an Century Shengkang Pharmaceutical is a specialized pharmaceutical enterprise based in China, primarily focused on the nephrology and cardiovascular therapeutic areas. Established in 2001, the company has built a significant presence in the treatment of chronic kidney disease (CKD) through its proprietary formulations and modern Traditional Chinese Medicine (TCM) products. In 2015, the company was acquired by China Resources Double-Crane Pharmaceutical, integrating it into one of China's largest healthcare conglomerates. Century Shengkang operates large-scale, GMP-compliant manufacturing bases in Xi'an and continues to drive growth through its established commercial portfolio. Its flagship products, including the Shengkang brand of treatments, are widely utilized in hospitals across China for managing renal complications and improving patient outcomes. The company's integration into the China Resources Group has expanded its R&D capabilities and market reach within the domestic pharmaceutical industry.